SMi are presenting their inaugural conference on Peptide Therapeutics.
As the global Peptide Therapeutics market is expected to reach over $25 billion by 2018, the market is strongly trying to develop new peptide therapeutics and better formulations to enhance drug delivery. Even though peptides is a relatively niche market – it has a fast growth rate with many products in development.
The conference will enable you to assess biophysical characterisation such as solubility and stability in addition to reviewing analytcial techniques for monitoring peptides. Focus is on optimisation, extending the half-life and assessing alternative technologies in peptide analysis.
Attention to detail is key in the formulation and delivery of peptides and SMi pride themselves in delivering a thorough conference with this focus in mind. Presentations will include the assessment of new formulations and routes of administration i.e. oral, as well as reviewing compliance and efficacy challenges.
Electronic Access - Single User Fulfilled By Publisher